Type 2 diabetes trials in Brazil

In Brazil 39 Also abroad 1247

39 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Aracaju - SE, Belo Horizonte, Blumenau, Brasília, Campinas, Curitiba, Fortaleza, Goiânia, Joinville, Maceió, Manaus, Natal, Porto Alegre, Ribeirão Preto, Rio de Janeiro, Santa Cecília, São José do Rio Preto, São Paulo
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Not yet taking people in Brazil
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
Where
Campinas, Porto Alegre, São Paulo
Age
18 years and over
People
450 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00
Phase 3Not yet taking people in Brazil
AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
Where
Campinas, Curitiba, Porto Alegre, São Paulo
Age
18 years and over
People
1,200 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00
Phase 3Not yet taking people in Brazil
A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
Where
Campinas, Manaus, Porto Alegre, São Paulo
Age
18 years and over
People
1,060 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Goiânia, Natal, Porto Alegre, São José do Rio Preto, São Paulo
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Aracaju, Goiânia, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São Paulo
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Belo Horizonte, Campinas, São Paulo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Brasília, Campinas, São José do Rio Preto, São Paulo
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Campinas, Goiânia, Passo Fundo, Porto Alegre, São Paulo
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Curitiba, Fortaleza, São Paulo, Vitória, Votuporanga
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Brazil
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Aracaju, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, Recife, Rio de Janeiro, São Paulo, Vitória
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Barretos, Brasília, Campinas, Curitiba, Fortaleza, Natal, Porto Alegre, Rio de Janeiro, São José dos Campos, São Paulo
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Belo Horizonte, Brasília, Campinas, Curitiba, Natal, Porto Alegre, Rio de Janeiro, São José dos Campos, São Paulo
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
No phaseNot yet taking people in Brazil
Evaluation of the Effectiveness of Implementing a Screening Strategy for the Diagnosis of Prediabetes and Type 2 Diabetes Mellitus in Primary Health Care in a Brazilian Municipality
Where
Afogados da Ingazeira, Florianópolis
Age
18 years and over
People
45,000
Run by
epHealth
See details and how to joinNCT07846319
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Brasília, Campinas, Curitiba, Natal, Porto Alegre, São José dos Campos, São Paulo
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
No phaseTaking people
Systemic Biochemical Signature and Functional Quality Index of Calcaneal Bone Marrow Aspirate in Adults Undergoing Foot or Ankle Surgery
Where
Bragança Paulista
Age
40 years to 80 years
People
40
Run by
Universidade Sao Francisco
See details and how to joinNCT07802106
Phase 3Taking people
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Where
Bairro Rodolfo Teófilo, Fortaleza, Curitiba, Porto Alegre, Ribeirão Preto, São Paulo
Age
10 years to 18 years
People
80 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07282613
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Belém, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, São José dos Campos, São Paulo
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 2Taking people
Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes
Where
Porto Alegre
Age
30 years to 80 years
People
94
Run by
Hospital de Clinicas de Porto Alegre
See details and how to joinNCT04874012
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Brasília, Campinas, Fortaleza, Marília, Porto Alegre, Rio de Janeiro, São Paulo
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Bragança Paulista, Brasília, Campina Grande do Sul, Colatina, Curitiba, Fortaleza, Goiânia, Joinville, Poços de Caldas, Salvador, Santa Cruz do Sul, São Caetano do Sul, São Paulo, Teresina
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Aparecida de Goiânia, Belém, Bragança Paulista, Brasília, Campinas, Curitiba, Fortaleza, Goiânia, Manaus, Sao Jose Rio Preto, São Paulo, Uberlândia, Volta Redonda
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Where
Barretos, Brasília, Campinas, Curitiba, Fortaleza, Natal, Porto Alegre, Rio de Janeiro, São José dos Campos, São Paulo
Age
18 years and over
People
2,150 worldwide
Run by
AstraZeneca
See details and how to joinNCT07606066
No phaseTaking people
Effectiveness of the Brazilian Diabetes Prevention Program
Where
Goiânia, Viçosa
Age
18 years and over
People
1,305
Run by
Beneficência Portuguesa de São Paulo
See details and how to joinNCT06426277